병용 의약

RET 키나아제 저해활성을 갖는 화합물 및 CDK4／6 저해제를 조합함으로써, 암을 치료 또는 예방하기 위해 효과적인 의약, 조합, 의약 조성물, 제제, 암을 치료 또는 예방하는 방법, 또는 종양의 증식을 억제하기 위한 방법을 발견하였다. By combining a compound having RET kinase inhibitory activity with a CDK4/6 inhibitor, the present inventors have found a drug, a combination, a pharmaceutical compos...

Full description

Saved in:
Bibliographic Details
Main Authors YOSHIMURA YASUSHI, FUJIMURA TAKAAKI, FURUGAKI KOH, HARADA NAOKI
Format Patent
LanguageKorean
Published 19.07.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:RET 키나아제 저해활성을 갖는 화합물 및 CDK4／6 저해제를 조합함으로써, 암을 치료 또는 예방하기 위해 효과적인 의약, 조합, 의약 조성물, 제제, 암을 치료 또는 예방하는 방법, 또는 종양의 증식을 억제하기 위한 방법을 발견하였다. By combining a compound having RET kinase inhibitory activity with a CDK4/6 inhibitor, the present inventors have found a drug, a combination, a pharmaceutical composition, and a preparation which are effective for treating or preventing cancer, a method for treating or preventing cancer, or a method for suppressing tumor growth.
Bibliography:Application Number: KR20227019608